Johnson & Johnson (JNJ) Tops Q4 EPS by 11c, Revenues Misses; Guides EPS Above Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $263.81 -1.42%
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.35, $0.11 better than the analyst estimate of $2.24. Revenue for the quarter came in at $23.7 billion versus the consensus estimate of $23.9 billion.
GUIDANCE:
Johnson & Johnson sees FY2023 EPS of $10.50, versus the consensus of $10.33.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Erste Group Downgrades Johnson & Johnson (JNJ) to Hold
- Preferred Bank (PFBC) Tops Q3 EPS by 4c
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
